Myoclonus and metabolic alkalosis from licorice in antacid

Internal Medicine

Volumn 43, Issue 1, 2004, Pages 59-62

  Ishiguchi, Tadashi ^a   Mikita, Naoya ^a   Iwata, Takuya ^a   Nakata, Hiroya ^a   Sato, Hiroaki ^a   Higashimoto, Yuji ^a   Fujimoto, Hisashi ^a   Yoshida, Sohei ^b   Itoh, Hidekazu ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b Kansai College of Oriental Medicine   (Japan)

Author keywords

Antacid; Glycyrrhizin; Hypokalemia; Licorice; Metabolic alkalosis; Myoclonus

Indexed keywords

ALDOSTERONE; AMMONIUM CHLORIDE; ANTACID AGENT; BENIDIPINE; BICARBONATE; C REACTIVE PROTEIN; CALCIUM; CODEINE PHOSPHATE; CREATINE KINASE; DIHYDROCODEINE; DILTIAZEM; GLUCONATE CALCIUM; GLYCYRRHIZA EXTRACT; KALLIKREIN; KM POWDER; MAGNESIUM; PHOSPHATE; POTASSIUM CHLORIDE; PROCATEROL; RENIN; SENNOSIDE; SODIUM CHLORIDE;

ACID BASE BALANCE; AGED; ARTICLE; BLOOD PH; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG FORMULATION; DRUG INDUCED DISEASE; DRUG RESPONSE; FEMALE; GLYCYRRHIZA; HUMAN; HYPERTENSION; METABOLIC ALKALOSIS; MYOCLONUS; PHYSICAL EXAMINATION; PLASMA RENIN ACTIVITY; POWDER; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ALKALOSIS; ANTACIDS; BLOOD CHEMICAL ANALYSIS; FEMALE; FOLLOW-UP STUDIES; GLYCYRRHIZA; HUMANS; MYOCLONUS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 1142287403     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.59     Document Type: Article

References (14)

1. Martin WJ, Matzke GR. Treating severe metabolic alkalosis. Clin Pharm 1: 42-48, 1982.
2. Fraley DS, Adler S, Bruns F. Life-threatening metabolic alkalosis in a comatose patient. South Med J 172: 1024-1025, 1979.
3. Adachi M, Ikemoto Y, Kubo K, Takuma C. Seizure-like movements during induction of anaesthesia with sevoflurane. Br J Anaesth 68: 214-215, 1992.
4. Victor M. The role of hypomagnesemia and respiratory alkalosis in the genesis of alcohol-withdrawal symptoms. Ann N Y Acad Sci 215: 235-248, 1973.
5. Khanna A, Kurtzman NA. Metabolic alkalosis. Respir Care 46: 354-365, 2001.
6. Kassirer JP. Serious acid-base disorders. N Engl J Med 291: 773-776, 1974.
7. Abelow B. Understanding acid-base. 1st. ed. Williams & Wilkins, Baltimore, 1997: 299-305.
8. Bartholow C, Whittier FC, Rutecki GW. Hypokalemia and metabolic alkalosis: algorithms for combined clinical problem solving. Compr Ther 26: 114-120, 2000.
9. Edwards CR, Stewart PM, Burt D, et al. Localisation of 11 beta-hydroxysteroid dehydrogenase - tissue specific protector of the mineralocorticoid receptor. Lancet 2: 986-989, 1988.
10. Caviness JN. Myoclonus. Mayo Clin Proc 71: 679-688, 1996.
11. Okada K, Kono N, Kobayashi S, Yamaguchi S. Metabolic alkalosis and myoclonus from antacid ingestion. Intern Med 35: 515-516, 1996.
12. Weisleder P, Tobin JA, Kerrigan JF 3rd, Bodensteiner JB. Hypomagnesemic seizures: case report and presumed pathophysiology. J Child Neurol 17: 59-61, 2002.
13. Wyllie E, Lueders H, Pippenger C, VanLente F. Postictal serum creatine kinase in the diagnosis of seizure disorders. Arch Neurol 42: 123-126, 1985.
14. Peltola J, Laaksonen J, Haapala AM, Hurme M, Rainesalo S, Keranen T. Indicators of inflammation after recent tonic-clonic epileptic seizures correlate with plasma interleukin-6 levels. Seizure 11: 44-46, 2002.